Posted 10 May, 2021
Anebulo Pharmaceuticals, Inc. IPO completed
IPO completed detected for ticker Nasdaq:ANEB in a 424B4 filed on 10 May, 2021.
This is the initial public offering of common stock of Anebulo Pharmaceuticals, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Anebulo Pharmaceuticals, Inc.
Health Care/Life Sciences • Pharmaceuticals
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.Market Cap
$42.3M
View Company Details
$42.3M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.